KEHLER JAN has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Israel and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are RAQUALIA PHARMA INC, TAKEDA PHARMACEUTICAL COMPANY LIMITED and PALOBIOFARMA SL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 7 | |
#2 | United States | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Kehler Jan | 12 |
#2 | Juhl Karsten | 9 |
#3 | Rasmussen Lars Kyhn | 7 |
#4 | Langgard Morten | 7 |
#5 | Vital Paulo Jorge Vieira | 7 |
#6 | Jessing Mikkel | 7 |
#7 | Marigo Mauro | 6 |
#8 | Clementson Carl Martin Sebastian | 3 |
#9 | Noergaard Morten Bang | 1 |
#10 | Nielsen Jacob | 1 |
Publication | Filing date | Title |
---|---|---|
US2012129836A1 | Tricyclic imidazole compounds as PDE10 inhibitors |